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Abstract
Objective: fibrosing colonopathy (fc) is a rare entity
associated with cystic fibrosis (cf). until now, patients
with stricturing fc have usually been treated surgically.
In this instance, we aimed at avoiding surgery by ap-
plying a new conservative approach. 
Methods: case report on an adult with cf who devel-
oped persistent abdominal pain due to a non-passable
stricture in the right transverse colon. Histology con-
firmed fibrosing colonopathy.
Results:  Initially  we  treated  the  patient  with  pred-
nisolone pulse therapy and additive antibiotic therapy.
for maintenance therapy we administered budesonide.
The patient underwent clinical, laboratory and endo-
scopic follow-up over a three-year period. The stric-
ture healed and was easy to pass. a relapse in the ce-
cum  at  the  ileocecal  valve  again  improved  under
steroid and antibiotic therapy.
Conclusions: We present a novel therapeutic approach
for advanced stricturing fc in an adult patient which
successfully  avoided  surgery  (right  hemicolectomy)
over a three year follow up. 
Key  words:  fibrosing  colonopathy;  cystic  fibrosis;
colonic stricture
caSE REPoRT
a 25-year-old man suffering from pre-existing cystic
fibrosis was admitted with persistent pain in the right
lower-quadrant. He reported a history of meconium
ileus at birth, appendectomy and recurrent distal in-
testinal obstruction syndrome (dIoS). His genotype
(compound heterozygote Δf508/R553X) is associated
with  pancreatic  insufficiency  [1].  Throughout  child-
hood he was substituted with high-strength pancreatic
enzymes (pancreatin 150.000 units/d). during adoles-
cence he took pancreatin 10.000 units for fat-rich nu-
trition only. on his first presentation in July 2007, the
patient reported about a 20-month history of recur-
rent pain in the right lower abdominal quadrant which
now had increased dramatically. under intake of laxa-
tives he had had daily bowel movements without visi-
ble blood. on admission he appeared in good physical
condition with a stable body weight (bMI 22.2kg/m²)
and physical examination revealed focal tenderness in
the  right-lower  quadrant  and  normal  bowel  sounds.
laboratory values showed an elevated c-reactive pro-
tein  (10.7mg/dl)  and  a  slight  anemia  (hemoglobin:
10.6g/dl).  Transabdominal  ultrasound  demonstrated
hypoechoic  bowel  wall  thickness  of  the  transverse
colon (10mm) and a 30mm long stricture in the right
transverse colon (fig. 1). The bowel wall of the as-
cending colon and cecum was mildly thickened, while
no  abnormalities  could  be  observed  in  the  terminal
ileum. colonoscopy was incomplete because of a non-
passable circular stricture in the right transverse colon
(fig. 1). distal of the stricture the colonic mucosa ap-
peared hyperemic, edematous and ulcerated for about
20cm.  The  remaining  left-sided  colon  did  not  show
any abnormalities. The histopathologic examination of
the endoscopic biopsies showed ulcerative inflamma-
tion,  cryptitis,  irregular  hyperplasia  of  goblet  cells,
submucosal fibrosis and disruption of the muscularis
mucosa  consistent  with  the  diagnosis  of  fibrosing
colonopathy (fig. 1). after the patient had given his
informed  consent  with  regard  to  the  experimental
character of the therapy we initiated intravenous pred-
nisolone pulse therapy (75mg/d) for 10 days followed
by a slow dose tapering (10mg/week to 25mg, than
5mg/week) over 10 weeks. In addition, we adminis-
tered intravenous antibiotic therapy (mezlocillin 6g/d,
metronidazole  1g/d).  The  patient`s  symptoms  im-
proved significantly and c-reactive protein levels de-
creased.  after  3  weeks  control-colonoscopy  showed
healed  ulcerations.  furthermore,  the  stricture  had
healed  with  some  minor  scars  remaining  and  could
now be passed allowing a view on the ascending colon
and cecum. Here we found multiple pseudopolyps and
a  lack  of  haustration  while  the  terminal  ileum  ap-
peared normal. Histologically, fc with residual inflam-
mation was confirmed. for maintenance therapy we
administered budesonide 9mg/d. Half a year later the
patient presented without any abdominal pain and in-
creasing body weight. He had further decreased the
dosage of budesonide to 6mg/d by himself. colono  -
scopy  showed  an  unchanged  status.  Therapy  with
budesonide 6mg/d was continued. 
However, in January 2009, 18 months after his first
admission,  the  patient  once  more  presented  with
crampy pain in the right lower abdominal quadrant.
While the region of the former stricture in the right
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eas of ulcerative inflammation in the cecum and at the
ileocecal valve which could not be passed due to in-
flammatory  stenosis.  as  during  the  first  episode  we
treated  the  patient  with  prednisolone  pulse  therapy
and antibiotics with again good clinical response and
administered  budesonide  9mg/d  for  maintenance
therapy. In July 2009, colonoscopy demonstrated that
EuRoPEaN JouRNal of MEdIcal RESEaRcH 412 September 12, 2011
Prior to treatment   07/2007 after treatment 03/2011
abdominal 
ultrasound
Hypoechoic bowel wall thickening (10mm)
of the transverse colon, unremarkable
bowel wall of the ascending colon and a
stricture of nearly 30mm length
colonoscopy
Non-passable circular stricture in the right
transverse colon with ulcerative inflamma-
tion
Scarredly healed and easily passable stric-
ture in the right transverse colon
Histology
colonic biopsy with hypercellular lamina
propria with lymphocytes, eosinophilic
granulocytes, ulcerative inflammation, ar-
chitectural distortion of the crypts and sub-
mucosal fibrosis
colonic  biopsy  with  regenerative  epitheli-
um, mucosal edema and lymphocytic infil-
trate in the lamina propria
Fig. 1.
7) Terheggen##_Umbruchvorlage  04.08.11  15:58  Seite 412the  stricture  in  the  right  transverse  colon  was  now
healed  and  easy  to  pass.  In  the  cecum  multiple
pseudopolyps  without  additional  inflammation  were
found. The ileocecal valve was constricted over a very
short  distance  and  nearly  passable  with  the  colono-
scope. 
finally after more than three years, in March 2011
the patient presented in an excellent physical condition
with  stable  weight  under  maintenance  therapy.  The
colonoscopy showed an unchanged status (fig. 1). 
dIScuSSIoN
fibrosing colonopathy is a rare entity associated to pa-
tients with cf. It has generally been reported in young
children approximately 12 months after exposure to
high dose pancreas enzyme supplementation (HdPE).
The exact etiopathogenesis still remains unsolved. Pre-
disposing factors are young age (2-13 years), history of
gastrointestinal  complications  (dIoS,  meconium
ileus), previous intestinal surgery, HdPE and use of
histamine H2-receptor blockers, corticosteroids or re-
combinant human deoxyribonuclease (dNase) [2]. To
our knowledge, only five cases of fc in adults were
reported [3-7]: three patients with cf, one developed
fc  after  HdPE  in  pancreatic  insufficiency  and  one
suspicious  of  crohn`s  disease  and  treated  with
mesalazine. Interestingly, development of fc in these
five adults was not clearly associated with HdPE: two
patients developed fc under treatment with HdPE,
one patient after discontinuation of HdPE and two
without HdPE at any time. all of these patients were
symptomatic due to strictures and the diagnosis of fc
was discovered during surgery.
clinical  symptoms  are  usually  those  of  intestinal
obstruction with abdominal pain, constipation or diar-
rhea and hematochezia. abnormal bowel wall thick-
ness is a common finding in cf, but it is usually not
associated with clinical features and is no predisposing
factor for fc [8, 9]. Endoscopy may demonstrate a fri-
able, hyperemic, edematous, stiff or ulcerated mucosa
often with strictures, colonic shortening and loss of
haustration. fc usually spares the rectum and may be
either segmental, mostly in the right colon, or involves
the complete colon. characteristic histologic features
include submucosal fibrosis, disruption of the muscu-
laris mucosa, ulcerative inflammation, eosinophilia and
cryptitis [10-13]. In contrast, in ulcerative colitis com-
mon features are an acute and chronic inflammatory
cell infiltrate, distortion of crypts, crypt abscesses and
goblet cell depletion. The differentiation to stricturing
crohn`s disease can be challenging in the absence of
characteristical epitheloid granuloma. 
To our knowledge this is the first report of a non-
passable colonic stricture in fc which was successfully
treated  without  surgical  intervention.  Treatment  was
based  on  an  antiinflammatory  concept  with  pred-
nisolone  pulse  therapy.  additional  antibiotic  therapy
aimed at treating bacterial translocation due to barrier
dysfunction of the intestinal mucosa. In order to avoid
side effects of longterm systemic steroids treatment
was continued with topical active budesonide. Howev-
er, maintenance therapy with budesonide did not pro-
tect the patient from a second stenosis at the cecum. If
clinical symptoms from this stenosis should accelerate
in the future, balloon dilatation of the ileocecal valve
or a limited surgical intervention might be the treat-
ment of choice. analogue to crohnﾴs disease mainte-
nance therapy with thiopurins might be another exper-
imental  option.  However,  until  now  we  avoided  the
risk of long-term immunosuppression due to the fear
of bronchopulmonary infections in cf. body weight
(bMI 25kg/m²) and physical condition improved un-
der therapy with budesonide. Interestingly, lung func-
tion improved remarkably under therapy demonstrat-
ing  an  increase  of  forced  expiratory  volume  in  one
second (fEv1) from 67% to 93% which may point to
a relationship between the inflammatory status of the
bowel and pulmonary affection in cf. according to
the current guidelines we recommended a pancreatic
enzyme  supplementation  on  demand  which  should
not exceed 10.000 units of lipase per kg per day [14,
15]. 
In conclusion, this case demonstrates a non-pass-
able colonic stricture in fc which was discovered en-
doscopically and was successfully treated conservative-
ly over a three-year period. This suggests a new thera-
peutic approach in cf patients with stricturing fc. 
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